Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone vs dexamethasone for peritumoral edema during brain metastasis radiotherapy
ChiCTR2600121403Phase 3Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Hainan Medical University
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methylprednisolone and dexamethasone in brain metastases and cerebral edema (4 arms), sponsored by Second Affiliated Hospital of Hainan Medical University. Primary endpoints: Change in KPS score within 1 week after radiotherapy and Incidence of grade ≥2 hormone therapy-related adverse events. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
methylprednisolonedexamethasone
03
Conditions
brain metastasescerebral edema
Beyond the preview
Go deeper on ChiCTR2600121403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121403.